# Task B23: Comprehensive In Vitro Antiviral Screening Against Viruses of Pandemic Potential Under the Antiviral Program for Pandemics (APP) to Support Hit-to-Lead Studies

> **NIH NIH N01** · UTAH STATE UNIVERSITY · 2024 · $8,967

## Abstract

This contract provides in vitro testing of potential anti-viral agents, maintenance of viral stocks and cell lines needed to grow the viruses, and development of related assays.

## Key facts

- **NIH application ID:** 11047619
- **Project number:** 75N93019D00021-P00001-759302300003-1
- **Recipient organization:** UTAH STATE UNIVERSITY
- **Principal Investigator:** JUSTIN JULANDER
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $8,967
- **Award type:** —
- **Project period:** 2023-09-05 → 2024-09-04

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11047619

## Citation

> US National Institutes of Health, RePORTER application 11047619, Task B23: Comprehensive In Vitro Antiviral Screening Against Viruses of Pandemic Potential Under the Antiviral Program for Pandemics (APP) to Support Hit-to-Lead Studies (75N93019D00021-P00001-759302300003-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/11047619. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*